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Abstract
Background: Anthranilate is an aromatic amine used industrially as an intermediate for the synthesis of dyes, perfumes,
pharmaceuticals and other classes of products. Chemical synthesis of anthranilate is an unsustainable process since it
implies the use of nonrenewable benzene and the generation of toxic by-products. In Escherichia coli anthranilate is
synthesized from chorismate by anthranilate synthase (TrpED) and then converted to phosphoribosyl anthranilate by
anthranilate phosphoribosyl transferase to continue the tryptophan biosynthetic pathway. With the purpose of
generating a microbial strain for anthranilate production from glucose, E. coli W3110 trpD9923, a mutant in the trpD gene
that displays low anthranilate producing capacity, was characterized and modified using metabolic engineering strategies.
Results: Sequencing of the trpED genes from E. coli W3110 trpD9923 revealed a nonsense mutation in the trpD gene,
causing the loss of anthranilate phosphoribosyl transferase activity, but maintaining anthranilate synthase activity, thus
causing anthranilate accumulation. The effects of expressing genes encoding a feedback inhibition resistant version of the
enzyme 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase (aroGfbr), transketolase (tktA), glucokinase (glk) and
galactose permease (galP), as well as phosphoenolpyruvate:sugar phosphotransferase system (PTS) inactivation on
anthranilate production capacity, were evaluated. In shake flask experiments with minimal medium, strains W3110
trpD9923 PTS- and W3110 trpD9923/pJLBaroGfbrtktA displayed the best production parameters, accumulating 0.70–0.75
g/L of anthranilate, with glucose-yields corresponding to 28–46% of the theoretical maximum. To study the effects of
extending the growth phase on anthranilate production a fed-batch fermentation process was developed using complex
medium, where strain W3110 trpD9923/pJLBaroGfbrtktA produced 14 g/L of anthranilate in 34 hours.
Conclusion: This work constitutes the first example of a microbial system for the environmentally-compatible synthesis
of anthranilate generated by metabolic engineering. The results presented here, including the characterization of
mutation in the trpD gene from strain W3110 trpD9923 and the development of a fermentation strategy, establish a step
forward towards the future improvement of a sustainable process for anthranilate production. In addition, the present
work provides very useful data regarding the positive and negative consequences of the evaluated metabolic engineering
strategies.
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Background
Anthranilate is an aromatic amine used as precursor for
the synthesis of compounds having applications in the
chemical, food and pharmaceutical industries. Current
anthranilate manufacture methods are based on chemical
synthesis using precursors derived from petroleum, such
as benzene. Also, chemical synthesis of anthranilate is a
multistep process requiring conditions of high tempera-
ture and pressure, which makes the process expensive for
commercial use [1,2]. Several microbial and plant species
have the metabolic capacity to synthesize this aromatic
compound, opening the possibility for generating sustain-
able technologies for anthranilate manufacture. This com-
pound is a metabolic intermediate and therefore it is
normally not accumulated. Anthranilate is an intermedi-
ate in the tryptophan biosynthetic pathway (Fig. 1). Car-
bon flow into the common aromatic pathway starts with
the condensation of D-erythrose 4-phosphate (E4P) and
phosphoenolpyruvate (PEP) to yield 3-deoxy-D-arabino-
heptulosonate 7-phosphate (DAHP), in a reaction cata-
lyzed by the enzyme DAHP synthase. After six more reac-
tions, chorismate is synthesized, leading to a branch point
where biosynthetic pathways for L-tryptophan (L-Trp), L-
tyrosine (L-Tyr) and L-phenylalanine (L-Phe) originate. In
Escherichia coli, the first two reactions in the L-Trp biosyn-
thetic pathway are catalyzed by the enzyme complex
anthranilate synthase-phosphoribosyl transferase (TrpE-
TrpD). It is a multifunctional and heterotetrameric com-
plex composed of two TrpE and two TrpD polypeptides
(component I and II, respectively). Component I (TrpE)
catalyses the conversion of chorismate and glutamine to
anthranilate, glutamate and pyruvate. The anthranilate
synthase activity is the result of aminase and amidotrans-
ferase activities that are encoded by trpE and the amino
terminal region encoded by trpGD, respectively (Fig. 2a).
Component II (TrpD) catalyses the transfer of the phos-
phoribosyl group of 5-phosphorylribose-l-pyrophosphate
to anthranilate, forming N-phosphoribosylanthranilate.
The carboxyl terminal region of TrpD has the anthranilate
phosphoribosyl transferase activity [3,4]. After five more
metabolic steps, L-Trp is synthesized.
Early studies on the polarity of the L-Trp operon in E. coli
enabled the identification of mutants that secreted anthra-
nilate [5]. The characterization of one of the strains
obtained by UV mutagenesis (W3110 trpD9923), revealed
that the mutation was present in the trpD  gene. These
results suggest the feasibility of modifying E. coli to gener-
ate strains for anthranilate production. With the purpose
of exploring a rational approach to improve the produc-
tion capacity of strain W3110 trpD9923, in this work we
characterized the mutation enabling anthranilate accu-
mulation. In addition, we studied the effect of overex-
pressing genes encoding a feedback inhibition resistant
DAHP synthase (aroGfbr), transketolase (tktA), glucoki-
nase (glk) and galactose permease (galP) on anthranilate
productivity and yield from glucose in strains having
either active or inactive PEP:sugar phosphotransferase sys-
tem (PTS).
Results
Characterization of E. coli W3110 trpD9923
The W3110 trpD9923  strain belongs to a set of E. coli
mutants obtained after random mutagenesis by UV light
Metabolic network related to anthranilate biosynthesis in E.  coli Figure 1
Metabolic network related to anthranilate biosynthe-
sis in E. coli. Arrows with dashed lines indicate more than 
one enzymatic reaction. Metabolite symbols: G6P, glucose 6-
phosphate; F6P, fructose 6-phosphate; F1,6DP fructose 1,6 
diphosphate; G3P, glyceraldehyde 3-phosphate; Ru5P, ribu-
lose 5-phosphate; R5P, ribose 5-phosphate; X5P, xylulose 5-
phosphate; S7P, sedoheptulose 7-phosphate; PYR, pyruvate; 
PEP, phosphoenolpyruvate; E4P, erythrose 4-phosphate; 
DAHP, 3-deoxy-D-arabino-heptulosonate 7-phosphate; 
CHA, chorismate; PPA, prephenate; ANT, anthranilate; L-
Gln, L-glutamine; L-Glu, L-glutamate; L-Phe, L-phenylalanine; 
L-Tyr, L-tyrosine; L-Trp, L-tryptophan. Protein and gene 
symbols: IICBGlc, glucose-specific integral membrane per-
mease; TCA, tricarboxylic acid cycle; PTS, phosphotrans-
ferase transport system; tktA, transketolase; aroGfbr, feedback 
inhibition resistant DAHP synthase; trpED, anthranilate syn-
thase-phosphoribosyl transferase complex.
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exposure, having mutations in the first three genes of the
tryptophan operon [5]. This report indicated that this
strain is a tryptophan auxotroph which accumulates
anthranilate. However, the specific mutation responsible
for this phenotype and the anthranilate production capac-
ity were not determined.
In order to characterize the mutation that causes anthrani-
late accumulation in this strain, the nucleotide sequence of
the trpEGD genes was determined and compared to the cor-
responding sequence from E. coli MG1655 [6]. This analy-
sis revealed a mutation at position 613, corresponding to
the eighth codon of the anthranilate phosphoribosyl trans-
ferase domain of the anthranilate synthase component II
(trpD), where a G to T transversion was detected, resulting
in the generation of a stop codon (Fig. 2b). This mutation
in trpD9923 results in the synthesis of a truncated anthrani-
late synthase component II protein, retaining the full
glutamine amidotransferase domain and only seven of the
333 amino acid residues of the anthranilate phosphoribo-
syl transferase domain (Fig. 2b). This mutation in the trpD
gene causes the loss of anthranilate phosphoribosyl trans-
ferase activity, but glutamine amidotransferase activity is
not affected. Therefore, anthranilate can be synthesized in
this strain, but it is not further metabolized to N-phos-
phoribosylanthranilate, thus causing anthranilate accumu-
lation and tryptophan auxotrophy.
To determine the anthranilate production capacity of
strain W3110 trpD9923, cultures were performed in shake
flasks with M9 mineral medium supplemented with 20
μg/mL tryptophan and 10 g/L of glucose at 37°C. Under
these conditions, this strain displayed a specific growth
rate (μ) of 0.26 ± 0.04 h-1(Table 1), a maximum biomass
concentration of 1.29 ± 0.03 gDCW/L in 16 h and no lag
phase was observed (Fig. 3a). The specific glucose con-
sumption rate (qGlc) was 0.34 ± 0.01 gGlc/gDCW·h. After a
12 h production phase, this strain accumulated 0.31 ±
0.01 g/L of anthranilate as the maximum concentration
(Fig. 3c) with a specific anthranilate production rate (qAnt)
of 0.02 ± 0.00 gAnt/gDCW·h and an anthranilate yield from
glucose (YAnt/Glc) of 0.06 ± 0.01 gAnt/gGlc (Table 1).
PTS inactivation in strain trpD9923
To improve the anthranilate production capacity of
W3110 trpD9923, two different and complementary met-
abolic engineering strategies were applied: one involved
increasing the availability of PEP and E4P; two metabolic
precursors for anthranilate biosynthesis, and the other
was based on redirecting carbon flow from central metab-
olism into the common aromatic pathway. Condensation
of PEP and E4P is the first step in the aromatic amino acid
biosynthesis pathway (Fig. 1). Several reported studies
have demonstrated that PEP is a limiting precursor with
regard to aromatics yield from glucose [7-9]. When E. coli
is growing with glucose as the carbon source, PTS is the
main activity that consumes PEP; therefore, it has been
identified as a target for inactivation to increase aromatics
production capacity [10-12]. In order to increase PEP bio-
synthetic availability in the cell, the PTS operon was inac-
Sequence determination of the trpEGD genes of E. coli trpD9923 Figure 2
Sequence determination of the trpEGD genes of E. coli trpD9923. (a) Organization of trpEGD genes of E. coli. (b) Com-
parison of the nucleotide and amino acid partial sequences of trpGD genes of E. coli MG1655 and E. coli trpD9923.
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Flask cultures of E. coli W3110 trpD9923 derivative strains for the production of anthranilate Figure 3
Flask cultures of E. coli W3110 trpD9923 derivative strains for the production of anthranilate. (a) Growth curves, 
(b) glucose consumption, and (c) anthranilate production. (filled circle) W3110 trpD9923; (open circle) W3110 trpD9923 PTS-; 
(filled square) W3110 trpD9923 PTS-/pv5Glk5GalP; (X) W3110 trpD9923/pJLBaroGfbr; (open triangle) W3110 trpD9923/pJL-
BaroGfbrtktA; (open square) W3110 trpD9923 PTS-/pJLBaroGfbrtktA; (filled triangle) W3110 trpD9923 PTS-/pv5Glk5GalP/pJL-
BaroGfbrtktA. Graphs show results from the mean of the triplicate experiments.
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tivated in strain W3110 trpD9923 by transduction of the
ΔptsHIcrr::kmR  mutation, generating strain W3110
trpD9923 PTS-. Flask cultures with this PTS- strain using
M9 mineral medium showed a significantly different
growth profile compared to that observed with the PTS+
strain W3110 trpD9923. Cultures with strain W3110
trpD9923 PTS- showed a 10 h lag phase and the maximum
biomass was 1.04 ± 0.05 gDCW/L in 44 h (Fig. 3a). This
diminished growth capacity was evident by a 65% lower μ
than that observed for W3110 trpD9923 (Table 1). Also,
glucose consumption rate in the PTS- strain was 62%
lower than the qGlc  of the progenitor strain. W3110
trpD9923 PTS- displayed a 24 h anthranilate production
phase, where the qAnt was 1.5-fold higher and the YAnt/Glc
2-fold higher than the corresponding values obtained in
the PTS+ strain cultures (Table 1). As a result, the PTS-
strain accumulated a 2.2-fold higher amount of anthrani-
late than W3110 trpD9923 (Fig. 3c). These results show
that PTS inactivation caused a positive effect on anthrani-
late production capacity.
Increasing glucose transport capacity in strain W3110 
trpD9923 PTS-
As expected, inactivation of PTS in W3110 trpD9923
caused a significant decrease in its qGlc, due to a reduced
capacity to import this sugar [12]. As a result, its growth
rate was severely affected. Thus, in order to increase the
glucose transport capacity, strain W3110 trpD9923 PTS-
was transformed with plasmid pv5Glk5GalP, which car-
ries the genes glk and galP encoding glucokinase (Glk) and
galactose permease (GalP), respectively. Expression of
these two proteins has been shown to restore glucose
import and phosphorylation activities; functions previ-
ously provided by the PTS [13]. Shake flask experiments
with strain W3110 trpD9923  PTS-/pv5Glk5GalP under
previously described conditions showed that expression
of glk and galP in the PTS- strain caused a positive effect in
glucose assimilation capacity; the observed qGlc was 1.8-
fold higher than the value for the PTS- strain (Table 1).
Also, the μ increased 2.2-fold with respect to that observed
for the PTS- strain. Values for YAnt/Glc were similar to those
in the PTS- strain and qAnt increased 1.3-fold (Table 1).
However, the anthranilate production phase was reduced
to 8 h due to faster glucose consumption; therefore, a
lower anthranilate titer of 0.33 ± 0.01 g/L was reached at
the end of the culture (Fig. 3c).
Redirection of glycolytic and pentose phosphate pathway 
precursors to the common aromatic amino acid 
biosynthetic pathway
As mentioned before, condensation of PEP and E4P gen-
erates DAHP by action of DAHP synthase (Fig. 1). How-
ever this enzyme is highly regulated by allosteric control.
Thus, to increase cellular DAHP synthase activity, strain
W3110  trpD9923  was transformed with plasmid pJL-
BaroGfbr [14], which harbors the aroGfbr gene encoding a
feedback inhibition resistant mutant of DAHP synthase.
Increased dosage of aroGfbr caused an increase in the qAnt
and YAnt/Glc (3.5 and 2.7-fold, respectively), and 1.4-fold
higher anthranilate accumulation in comparison with the
parental strain. Increasing DAHP synthase activity causes
a higher demand for E4P; therefore, to avoid a limitation
for this intermediate, it is necessary to increase the activity
of the enzyme that synthesizes it. A way to achieve this is
through the high level expression of the enzyme transke-
tolase, responsible for E4P production. Therefore, to eval-
uate the effect of the co-expression of tktA on anthranilate
production, this gene was cloned downstream of the
Table 1: Comparison of kinetic and fermentation parameters of E. coli W3110trpD9923 derivative strains in flask cultures
Strain Final biomass
(gDCW/L)
μ
(h-1)
qGlc
(gGlc/gDCW·h)
qAnt
(gAnt/gDCW·h)
YBiom/Glc
(gDCW/gGlc)
YAnt/Glc
(gAnt/gGlc)
Final anthranilate 
titer (g/L)
W3110 trpD9923 1.29 ± 0.03
[16 h]a
0.26 ± 0.04
[0–12 h]b
0.34 ± 0.01
[0–16 h]
0.02 ± 0.00
[8–20 h]
0.18 ± 0.01
[0–16 h]
0.06 ± 0.01
[8–20 h]
0.31 ± 0.01
W3110trpD9923PTS- 1.04 ± 0.05
[44 h]
0.09 ± 0.01
[24–36 h]
0.13 ± 0.01
[0–44 h]
0.03 ± 0.00
[28–52 h]
0.18 ± 0.01
[0–44 h]
0.12 ± 0.01
[28–52 h]
0.70 ± 0.07
W3110 trpD9923PTS-/
pv5Glk5GalP
0.94 ± 0.05
[32 h]
0.20 ± 0.01
[8–16 h]
0.24 ± 0.03
[0–20 h]
0.04 ± 0.00
[8–16 h]
0.15 ± 0.02
[0–20 h]
0.12 ± 0.00
[8–16 h]
0.33 ± 0.01
W3110 trpD9923/
pJLBaroGfbr
1.09 ± 0.01
[16 h]
0.20 ± 0.00
[0–12 h]
0.30 ± 0.01
[0–12 h]
0.07 ± 0.00
[4–12 h]
0.28 ± 0.01
[0–12 h]
0.16 ± 0.01
[4–12 h]
0.44 ± 0.00
W3110 trpD9923/
pJLBaroGfbrtktA
0.93 ± 0.04
[20 h]
0.24 ± 0.00
[0–12 h]
0.37 ± 0.02
[0–16 h]
0.07 ± 0.00
[8–20 h]
0.17 ± 0.01
[0–16 h]
0.20 ± 0.05
[8–20 h]
0.75 ± 0.04
W3110 trpD9923PTS-/
pJLBaroGfbrtktA
0.39 ± 0.00
[32 h]
0.15 ± 0.01
[4–16 h]
0.43 ± 0.04
[0–24 h]
0.03 ± 0.00
[12–44 h]
0.10 ± 0.01
[0–24 h]
0.10 ± 0.02
[12–44 h]
0.45 ± 0.02
W3110 trpD9923PTS-/
pv5Glk5GalP/
pJLBaroGfbrtktA
0.79 ± 0.03
[24 h]
0.24 ± 0.00
[4–12 h]
0.21 ± 0.00
[0–28 h]
0.020 ± 0.00
[20–40 h]
0.19 ± 0.00
[0–28 h]
0.14 ± 0.03
[20–40 h]
0.33 ± 0.02
a values in brackets indicate the time maximum biomass was achieved b values in brackets indicate the period considered for calculation of kinetic 
parameters.Microbial Cell Factories 2009, 8:19 http://www.microbialcellfactories.com/content/8/1/19
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aroGfbr gene, generating the plasmid pJLBaroGfbrtktA. Co-
expression of aroGfbr and tktA in strain W3110 trpD9923
did not affect significantly the μ, qGlc, and qAnt parameters,
in comparison with strain W3110 trpD9923/pJLBaroGfbr.
However, the presence of tktA gene in the plasmid pJL-
BaroGfbr caused a 1.2-fold increase in YAnt/Glc, resulting in
a 1.7-fold higher anthranilate final titer (Table 1) with
respect to the strain expressing only aroGfbr. Although the
final anthranilate titer accumulated by W3110 trpD9923/
pJLBaroGfbrtktA is comparable to that produced by W3110
trpD9923  PTS-, the qAnt of the former strain is 2.3-fold
higher (Table 1). The maximum theoretical yield (maxYAnt/
Glc) of anthranilate from glucose is 0.435 gAnt/gGlc, consid-
ering this value, the YAnt/Glc from W3110 trpD9923/pJL-
BaroGfbrtktA strain corresponded to 46% of the maxYAnt/Glc.
Previous results demonstrated that the simultaneous
expression of aroGfbr and  tktA  genes caused a 3.3-fold
increase in YAnt/Glc and a 2.4-fold increase in the anthrani-
late titer in strain W3110 trpD9923, thus, in order to
increase carbon flux into aromatic biosynthesis and E4P
availability, strains W3110 trpD9923  PTS-  and W3110
trpD9923 PTS-/pv5Glk5GalP were transformed with plas-
mid pJLBaroGfbrtktA. The presence of plasmid pJLBaroGf-
brtktA  in strain W3110 trpD9923  PTS-  had a negative
impact on the final biomass concentration corresponding
to 37% of the strain lacking this plasmid. When compared
to W3110 trpD9923 PTS-, no significant changes in qAnt
and YAnt/Glc were detected. However the final anthranilate
titer was 0.45 ± 0.02 g/L due to the lower biomass concen-
tration (Fig. 3c). Transformation of strain W3110
trpD9923  PTS-/pv5Glk5GalP with plasmid pJLBaroGf-
brtktA did not have a significant effect on its growth capac-
ity and the qGlc. In contrast, the qAnt decreased 2-fold but
the production phase was 2.5-fold longer than that from
the isogenic strain lacking pJLBaroGfbrtktA, therefore, sim-
ilar final anthranilate titers were produced by both strains
(Table 1).
Fed-batch fermentor cultures for anthranilate production
Previous results indicated that anthranilate accumulation
occurs mainly during the growth phase in all studied
strains. Therefore, to study the effect of extending the
growth phase on anthranilate production, all strains were
cultured in a fermentor using a fed-batch system with
complex medium where a total of 30 g/L yeast extract and
90 g/L glucose were fed in order to improve the final bio-
mass concentration. As Figure 4 shows, all strains dis-
played growth, glucose consumption and anthranilate
accumulation profiles similar to those observed in the
flask cultures (Fig. 3). By using a fed-batch process, final
biomass concentration was increased an average of 19-
fold among all strains (Fig. 4a), when compared to shake-
flask conditions (Fig. 3a), likewise, the anthranilate pro-
duction phase and final anthranilate titer were increased
an average of 1.6-fold and 19.4-fold (Fig. 4c), respectively.
Analysis of kinetic parameters (Table 2) of all fermentor
cultures demonstrated that W3110 trpD9923/pJLBaroGf-
brtktA was the best anthranilate producer strain. It accu-
mulated 14 g/L of anthranilate in 34 h with a YAnt/Glc of
0.20 ± 0.00 gAnt/gGlc, the highest values observed among
all W3110 trpD9923 derivatives (Table 2). It should be
noted that the YAnt/Glc values presented in Table 2 are use-
ful only for comparison among strains grown in the fed
batch conditions, since nutrients present in the yeast
extract could provide precursors for anthranilate synthe-
sis. With respect to acetic acid production, final titer in
W3110 trpD9923 strain was 9.65 ± 2.17 g/L (Table 2). In
contrast, a much lower amount of acetic acid (0.50 ± 0.1
g/L) was detected in the medium of W3110 trpD9923/pJL-
BaroGfbrtktA cultures. In addition, PTS inactivation caused
a severe reduction in the production of acetic acid, as it
was not detected in the supernatants of all PTS- strains
(Table 2).
Discussion
In this work, molecular characterization of the trpD9923
mutant allele demonstrated that UV-light treatment gen-
erated a nonsense mutation in the trpD gene. As a result of
this mutation, gene trpD9923 encodes a truncated anthra-
nilate synthase component II, strongly suggesting that the
mutant protein retained glutamine amidotransferase
activity and lost the anthranilate phosphoribosyl trans-
ferase function. This assumption is consistent with the
observed phenotype of strain W3110 trpD9923 (anthrani-
late accumulation and L-Trp auxotrophy). The identifica-
tion of the locus and the type of mutation present in strain
W3110 trpD9923 will facilitate future efforts for the con-
struction of anthranilate production strains by enabling
the generation or transfer of this mutant allele to different
microbial species.
Cultures in shake flask and fermentor allowed the charac-
terization of strain W3110 trpD9923 and derivatives with
genetic modifications expected to have an impact on
anthranilate production capacity. Under the fed-batch
conditions utilized in this work, strain W3110 trpD9923
produced 4.2 g/L of anthranilate. With the purpose of
improving its performance as a production strain, W3110
trpD9923 was subjected to genetic modifications, follow-
ing several metabolic engineering strategies expected to
improve microbial strains for the production of aromatic
amino acids, and more recently in the production of chor-
ismate-derived fine chemicals [15-17]. A key target for
improving aromatic amino acids production capacity is
the modification of central metabolism to increase PEP
and E4P availability [7-9]. Fifty percent of the PEP gener-
ated in glycolysis is spent in glucose uptake by the PTS. As
the major PEP consuming activity in E. coli, PTS is the
main target for inactivation to increase precursor availa-Microbial Cell Factories 2009, 8:19 http://www.microbialcellfactories.com/content/8/1/19
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Fermentor cultures of E. coli W3110 trpD9923 derivative strains for the production of anthranilate Figure 4
Fermentor cultures of E. coli W3110 trpD9923 derivative strains for the production of anthranilate. (a) Growth 
curves, (b) glucose consumption, and (c) anthranilate production. (filled circle) W3110 trpD9923; (open circle) W3110 
trpD9923 PTS-; (filled square) W3110 trpD9923 PTS-/pv5Glk5GalP; (X) W3110 trpD9923/pJLBaroGfbr; (open triangle) W3110 
trpD9923/pJLBaroGfbrtktA; (open square) W3110 trpD9923 PTS-/pJLBaroGfbrtktA; (filled triangle) W3110 trpD9923 PTS-/
pv5Glk5GalP/pJLBaroGfbrtktA. Graphs show results from the mean of the duplicate experiments.
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bility for aromatic compounds [10,11]. PTS inactivation
in W3110 trpD9923  caused a 3.2-fold increase in the
anthranilate titer in fed batch cultures. Also, PTS inactiva-
tion caused a severe reduction in acetic acid production in
comparison with the PTS+ strain, eliminating the negative
effect of acetate accumulation that is responsible for
growth and productivity reduction [18-20].
However, an expected consequence of PTS inactivation
was a reduction in qGlc, resulting in 60% lower growth rate
of W3110 trpD9923 PTS-. It has been demonstrated that
expression of galP and glk genes increases glucose internal-
ization and glycolytic flux to fermentation products in
PTS- mutants [10,13,21,22]. In W3110 trpD9923 PTS- the
presence of plasmid pv5Glk5GalP effectively increased
glucose assimilation capacity as was evident by the higher
values of μ and qGlc than those present in W3110 trpD9923
PTS-strain. However, in fed batch cultures, YAnt/Glc and
anthranilate titer were reduced in W3110 trpD9923 PTS-/
pv5Glk5GalP. A similar effect was reported by Chen et al.
[23], where galP expression was ineffective in increasing
the L-Phe titers in an E. coli PTS- strain. A possible expla-
nation for this result is that glucose imported by GalP
must be phosphorylated by glucokinase, using ATP as the
phosphate donor, thus possibly having a negative impact
on the cell's energy balance, growth capacity and produc-
tivity. An alternate explanation is that the lower qGlc alters
carbon flux distribution, resulting in a negative impact on
biosynthetic metabolism. This negative effect was evident
by the affected growth capacity of PTS- strain and also by
the lower values of YBiom/Glc observed in strains PTS- trans-
formed with plasmid pv5Glk5GalP and/or pJLBaroGf-
brtktA (Tables 1 and 2). Metabolic flux redirection in
several segments of central metabolism has been reported
as a consequence of PTS inactivation and the correspond-
ing lower glucose transport capacity in E. coli [24].
As mentioned, inactivation of PTS is a common modifica-
tion to improve aromatics biosynthesis in E. coli. The PTS-
strains are always further modified to increase their glu-
cose transport capacity, either by isolating spontaneous
mutants of by expressing genes encoding alternate glucose
transport and phosphorylating activities [10,22]. In this
work, it was found that the residual glucose transport
capacity of a PTS- strain is sufficient to allow relatively
high anthranilate production capacity. In both shake flask
and fermentor cultures, strain W3110 trpD9923 PTS- dis-
played the second highest final anthranilate titer of all
studied strains; however, the productivity was low. When
the qGlc and growth capacity were improved in this strain
by the expression of galP and glk genes, the final anthrani-
late titer was reduced. These results suggest that fine-tun-
Table 2: Comparison of kinetic and fermentation parameters of E. coli W3110trpD9923 derivative strains in fed-batch fermentor 
cultures
Strain Final biomass
(gDCW/L)
μ
(h-1)
qGlc
(gGlc/gDCW·h)
qAnt
(gAnt/gDCW·h)
YBiom/Glc
(gDCW/gGlc)
YAnt/Glc
(gAnt/gGlc)
Final 
anthranilate 
titer
(g/L)
Final acetate 
titer
(g/L)
W3110 
trpD9923
21.35 ± 3.76
[34 h]a
0.25 ± 0.02
[2–10 h]b
0.17 ± 0.01
[0–34 h]
0.01 ± 0.00
[6–30 h]
0.27 ± 0.02
[0–34 h]
0.08 ± 0.01
[6–30 h]
4.21 ± 0.03 9.65 ± 2.17
W3110 
trpD9923PTS-
23.30 ± 0.56
[62 h]
0.10 ± 0.00
[6–18 h]
0.06 ± 0.00
[0–62 h]
0.01 ± 0.00
[14–72 h]
0.28 ± 0.00
[0–62 h]
0.15 ± 0.00
[14–72 h]
13.30 ± 0.89 NDc
W3110 
trpD9923PTS-/
pv5Glk5GalP
14.66 ± 1.26
[38 h]
0.15 ± 0.00
[6–18 h]
0.13 ± 0.02
[0–38 h]
0.01 ± 0.00
[10–34 h]
0.20 ± 0.03
[0–38 h]
0.09 ± 0.00
[10–34 h]
5.30 ± 0.07 ND
W3110 
trpD9923/
pJLBaroGfbr
19.47 ± 0.12
[34 h]
0.21 ± 0.00
[2–14 h]
0.12 ± 0.01
[0–30 h]
0.01 ± 0.00
[2–38 h]
0.28 ± 0.02
[0–30 h]
0.08 ± 0.002
[2–38 h]
6.72 ± 0.01 3.18 ± 0.52
W3110 
trpD9923/
pJLBaroGfbrtkt
A
18.54 ± 0.19
[34 h]
0.18 ± 0.01
[6–18 h]
0.14 ± 0.01
[0–34 h]
0.02 ± 0.00
[2–34 h]
0.24 ± 0.02
[0–34 h]
0.20 ± 0.00
[2–34 h]
14.00 ± 0.07 0.50 ± 0.1
W3110 
trpD9923PTS-/
pJLBaroGfbrtkt
A
11.12 ± 0.25
[38 h]
0.13 ± 0.00
[10–26 h]
0.16 ± 0.01
[0–34 h]
0.02 ± 0.00
[6–38 h]
0.19 ± 0.02
[0–34 h]
0.11 ± 0.00
[6–38 h]
7.16 ± 0.53 ND
W3110 
trpD9923PTS-/
pv5Glk5GalP/
pJLBaroGfbrtkt
A
15.40 ± 0.14
[38 h]
0.16 ± 0.00
[10–22 h]
0.15 ± 0.01
[0–30 h]
0.02 ± 0.01
[10–34 h]
0.23 ± 0.02
[0–30 h]
0.09 ± 0.01
[10–34 h]
5.08 ± 0.06 ND
a values in brackets indicate the time maximum biomass was achieved b values in brackets indicate the period considered for calculation of kinetic 
parameters. c ND, non detectable levels.Microbial Cell Factories 2009, 8:19 http://www.microbialcellfactories.com/content/8/1/19
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ing the expression level of galP and glk could allow the
development of PTS- production strains having both ade-
quate growth and anthranilate production capacities.
In a wild type E. coli strain, carbon flow into the common
aromatic pathway represents only 1.5% of the glucose
uptake rate [24]. This is the result of tight regulation of the
DAHP synthase isozymes that control carbon entry into
this pathway [15]. To overcome this limitation, feedback
resistant mutant versions of either one of the three DAHP
synthase isozymes have been expressed in engineered aro-
matics production strains [8,14,25,26]. In the present
work, expression of the feedback resistant DAHP synthase
aroGfbr in fermentor cultures resulted in a 1.6-fold higher
amount of anthranilate accumulated in comparison to
W3110 trpD9923  strain, also higher values of qAnt and
YAnt/Glc were achieved. In addition to aroGfbr expression,
overexpression of the non-oxidative pentose pathway
enzyme; transketolase, has been shown to increase E4P
availability [27]. The co-expression of aroGfbr and  tktA
genes in strain W3110 trpD9923 resulted in elevated titers
of anthranilate; 14 g/L were obtained under fed-batch fer-
mentor culture. Also, the highest qAnt and YAnt/Glc values of
strain W3110 trpD9923/pJLBaroGfbrtktA evidenced the ele-
vated carbon flux redirection from central metabolism to
the product-forming pathway via  DAHP. Analysis of
kinetic and fermentation parameters from flask cultures of
W3110 trpD9923/pJLBaroGfbr and W3110 trpD9923/pJL-
BaroGfbrtktA, when compared to W3110 trpD9923, ena-
bled to determine that overexpression of aroGfbr and tktA
contributes with 80% and 20% of the increase in YAnt/Glc,
respectively. Co-expression of tktA in other E. coli engi-
neered strains has shown a 30–40% increment in aro-
matic products yields [25,28-30]. It was also observed that
co-expression of aroGfbr and tktA had an effect in acetic
acid production. The expression of aroGfbr caused a 3-fold
reduction in final acetic acid titer when compared to
W3110 trpD9923. Remarkably, the presence of plasmid
pJLBaroGfbrtktA in strain W3110 trpD9923 caused a 19.3-
fold reduction in the final acetate concentration. This
result can be explained considering that redirection of PEP
to the common aromatic pathway should reduce carbon
flow to pyruvate, an intermediate that is both a direct and
indirect precursor to acetic acid.
The presence of plasmid pJLBaroGfbrtktA in all W3110
trpD9923 derivatives caused an increase in qAnt. However,
the simultaneous presence of compatible plasmids pJL-
BaroGfbrtktA and pv5Glk5GalP in W3110 trpD9923 PTS-
resulted in low final biomass concentration, possibly
caused by plasmid and gene expression metabolic burden.
This negative effect was more pronounced in the trpD9923
PTS-/pJLBaroGfbrtktA strain, possibly due to a carbon and
energy limited condition caused by its lower glucose
import capacity resulting from an inactive PTS. Co-expres-
sion of aroGfbr and tktA genes caused a reduction in the
YBiom/Glc of 11% in the PTS+ strain and 32% in the PTS-
strain in comparison with their parental strains without
pJLBaroGfbrtktA plasmid (Tables 1 and 2). These results
suggest that the lower anthranilate titers observed in the
trpD9923  PTS-/pJLBaroGfbrtktA strain is consequence of
the susceptibility of the PTS- strain to the metabolic bur-
den caused by gene overexpression.
The microbial synthesis of anthranilate has been previ-
ously described using a Bacillus subtillis strain resistant to
sulfaguanidine and flourotryptophan [31]. It is reported
that fermentor cultures with this strain using minimal
medium, resulted in the production on 3.5 g/L of anthra-
nilate and 25 g/L of acetoin after 60 h. In contrast, fermen-
tor cultures using complex medium with strain W3110
trpD9923/pJLBaroGfbrtktA produced 14 g/L of anthranilate
in 34 h and a low level of acetate was detected (0.50 g/L).
The results presented in this work, including the character-
ization of mutation trpD9923 and the effects on strain
productivity of specific genetic modifications, will enable
further optimization work focused in exploring addi-
tional metabolic engineering strategies and process tech-
nology to improve the current E. coli-based production
system for the environmentally-compatible synthesis of
anthranilate. These efforts should include the evaluation
of using environmentally-friendly raw materials such as
lignocellulosic hydrolysates and other carbon sources; as
glycerol, for the production of anthranilate in a sustaina-
ble process.
Methods
Strains and plasmids
Bacterial strains and plasmids used in this study are
described in Table 3. E. coli strain W3110trpD9923 was
obtained from the E. coli Genetic Stock Center (Yale Uni-
versity, New Haven, CT). E. coli W3110 trpD9923 strain is
a mutant in the tryptophan operon obtained by treatment
with ultraviolet radiation [3]; it is a tryptophan auxo-
troph. A PTS- derivative of trpD9923 was obtained by P1
vir phage transduction using PB11 (ΔptsH, ptsI, crr::KmR)
strain as donor, as described by Flores et al [10].
Plasmid pJLBaroGfbr carries the aroGfbr gene encoding a
feedback inhibition resistant mutant version of the
enzyme DAHP synthase under transcriptional control of
the lacUV5 promoter [14]. To co-express from this plas-
mid the gene encoding transketolase, the tktA gene includ-
ing its native promoter region was amplified by PCR using
chromosomal DNA of E. coli W3110 as template and the
forward primer 5' GCGCAGCGGACGGGCGAG
TAGATTGCGCA3' and the reverse primer 5' CGCCTGT-
TCGTTATCTATTCCGCACGCGTCGCG 3', both primers
contain the FspI site (in bold). The tktA PCR product wasMicrobial Cell Factories 2009, 8:19 http://www.microbialcellfactories.com/content/8/1/19
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cloned into plasmid pJLBaroGfbr previously digested with
BstZ17I enzyme, to generate plasmid pJLBaroGfbrtktA.
Plasmid pv5Glk5GalP carries the glk  and  galP  genes,
encoding glucokinase (Glk) and galactose permease
(GalP), under transcriptional control of a trc-derived pro-
moter [13].
Nucleotide sequence determination of trpED genes
Chromosomal DNA (200 ng) from strain
W3110trpD9923 was used as template for PCR amplifica-
tion using a set of primers designed with the Clone Man-
ager v6.0 software (Scientific and Educational Software,
Durham, NC). The primers were designed to bind to dif-
ferent regions of the trpED genes, allowing the determina-
tion of the full sequence. Primers used were the following:
5'TAGAGAATAACCATGGAAACACAAAAACCG3',
5'CGCGGATCCCGGTTTGCATCATTTACCCTCG3',
5'CGATTACCAGCAGGCCTCCGGTTGCAGCGTGGTGG
CTGGCTCTAG3', 5'ATTCCAGTTCCATCCGGAATCC3',
5'ATCTCGTTCGGGTGCTCACC3',
5'CAGGAGAAAGCATCAGCACC3' and 5'GAGTTCGGTG
GCGTAGTGCG3'. PCR reactions were carried out with the
Elongase enzyme mix (Invitrogen, Carlsbad, CA) in
accordance with the supplier recommendations. PCR
products were analyzed for expected size and purified
using a PCR purification kit (Marligen, BioScience, Ijam-
sville, MD). Nucleotide sequences were determined from
PCR templates by the Taq FS Dye Terminator Cycle Fluo-
rescence-Based Sequencing method, with an Applied Bio-
systems Model 377-18 sequencer (Foster City, CA).
Growth media, inoculum preparation and culture 
conditions
Cells were routinely grown in Luria Bertani (LB) broth or
LB agar plates [32]. M9 mineral medium was used for
flask cultures, containing 10 g/L glucose, 6 g/L Na2HPO4,
0.5 g/L NaCl, 3 g/L KH2PO4, 1 g/L NH4Cl, 246.5 mg/L
MgSO4, 14.7 mg/L CaCl2 and 10 μg/mL vitamin B1, and
supplemented with 20 μg/mL tryptophan. Medium for
fermentor cultures contained 3 g/L Na2HPO4, 3 g/L
KH2PO4, 1.7 g/L (NH4)2HPO4 and 1 mL/L of trace ele-
ments solution. This solution contains 27 g/L FeCl3, 2 g/L
ZnCl3, CoCl2·6H2O, 2 g/L Na2MoO4·2H2O, 2 g/L
CaCl2·2H2O, 0.5 g/L H3BO3 and 100 mL/L HCl.
Fermentor medium initially contained 10 g/L of yeast
extract and 30 g/L of glucose. A total of two independent
pulses containing 30 g/L glucose and 10 g/L yeast extract
were added to the fermentor whenever glucose concentra-
tion in the medium decreased to 10 g/L. Each pulse con-
tained 25 mL of 60% glucose solution and 25 mL of 20%
yeast extract solution. Antibiotics were added to the corre-
sponding cultures at a final concentration of 30 μg/mL
spectomycin, 20 μg/mL tetracycline and 30 μg/mL kan-
amycin during selection, propagation and fermentation
stages.
Inoculum preparation was started using strain samples
from frozen vials that were cultured overnight at 37°C in
M9 mineral medium plates supplemented with 0.2% of
glucose and 20 μg/mL tryptophan, colonies from these
plates were used to inoculate baffled shake flasks. For fer-
mentor cultures, colonies from plates were grown in shake
flasks with 50 mL LB medium, after overnight culture at
37°C a sample was used for inoculation.
Flask cultures were done in 250 mL flasks containing 50
mL of M9, inoculated at an initial optical density at 600
nm (OD600 nm) of 0.1 and incubated for 60 h at 37°C and
300 rpm in an orbital shaker (Series 25, New Brunswick
Scientific, Inc., NJ).
Fermentor cultures were performed in 1 L stirred tank bio-
reactors (Applikon, The Netherlands), using a working
volume of 500 mL. Cultures were inoculated at an initial
OD600 nm of 0.5. pH was maintained at 7.0 by automatic
addition of a 12.5% NH4OH solution. Temperature was
controlled at 37°C. Airflow was set to 1 vvm. Dissolved
oxygen tension was measured with a polarographic oxy-
gen electrode (Applisens, Applikon) and maintained
Table 3: Escherichia coli strains and plasmids used in this work
Strain/Plasmid Characteristics Reference
Strains
PB11 JM101 [supE, thi, Δ(lac-proAB), F'] ΔptsHI, crr::kmR, glucose- [10]
W3110 trpD9923 W3110 [F-λ- INV (rrnD-rrnE) 1] tryptophan auxotroph, randomly mutagenized by treatment with ultraviolet 
radiation.
[5]
W3110 trpD9923 PTS- As W3110 trpD9923 but ΔptsHI, crr::kmR, glucose- This work
Plasmids
pJLBaroGfbr aroGfbr expressed from the lacUV5 promoter, lacIq and tet genes, tetracycline resistance, pACYC184 
replication origin.
[14]
pv5Glk5GalP glk and galP genes expressed from the trc5 promoter, spectinomycin resistance. pCL1920 replication origin. [13]
pJLBaroGfbrtktAp J L B aroGfbr derivative, containing the tktA gene with its native promoter. This workMicrobial Cell Factories 2009, 8:19 http://www.microbialcellfactories.com/content/8/1/19
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above 20% air saturation during all cultivation period by
modifying the impeller speed.
For cultures of strains carrying plasmid pJLBaroGfbr, pJL-
BaroGfbrtktA  and/or pv5Glk5GalP gene induction was
started by adding IPTG to a final concentration of 0.1 mM
at an OD600 nm of 0.6 for shake flask and 3.0 for fermentor
cultures.
Kinetic parameters calculation
For the characterization of the strains used in this work,
specific rates of growth (μ), glucose consumption (qGlc),
anthranilate production (qAnt), yield of biomass on glu-
cose (YBiom/Glc) and yield of anthranilate on glucose (YAnt/
Glc) were determined. μ, qGlc and YBiom/Glc were calculated
during exponential growth phase. Since growth rates and
anthranilate production kinetics differed among studied
strains, qAnt and YAnt/Glc were calculated considering only
the anthranilate production phase, defined as the time
period starting one sample (1 hour) before anthranilate is
detected up to the point when a sharp decrease in anthra-
nilate accumulation was observed. Flask cultures were
performed in triplicate and fermentor cultures in dupli-
cate. The values reported represent the mean of the exper-
iments performed.
Analytical methods
Biomass concentration was measured as OD600 nm using a
spectrophotometer (Beckman DU-70, Palo Alto, CA) and
converted to dry cell weight (DCW) considering that 1
OD600 nm = 0.37 gDCW/L [13]. Samples taken during culti-
vation period were centrifugated at 10000 rpm for 2 min.
Supernatant was filtered using 0.45 μm syringe-filter and
stored at -20°C for subsequent analysis. Glucose was
determined using an enzymatic analyzer (YSI 2700, YSI
Life Sciences, OH). Acetate was determined by high per-
formance liquid chromatography (HPLC) (Waters, Mil-
ford, MA), using an Aminex HPX-87H column (300 × 7.8
mm; Bio-Rad, Hercules, CA); running conditions were 5
mM H2SO4 as mobile phase, flow of 0.5 mL/min and tem-
perature of 50°C. Detection was performed by photodi-
ode array at 210 nm. Anthranilate was determined by
HPLC (Agilent Technologies, Palo Alto, CA) using a Syn-
ergy Hydro C18 4 μm column (4.6 × 150 mm, Phenom-
enex, Torrance, CA); running conditions were 0.1%
trifluoroacetic acid in 40% methanol as mobile phase,
flow of 0.5 mL/min. Detection was performed by photo-
diode array at 330 nm. The maximum theoretical yield of
anthranilate from glucose (maxYAnt/Glc) was determined by
applying elementary mode flux analysis using META-
TOOL [33].
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